天津科学技术出版社

自然杀伤细胞治疗在血液肿瘤中的应用与挑战

王乙雯 1,2#,李梦迪 3#,刘明娅 1,2,饶书权 1,2*
作者信息
  1. 1 中国医学科学院血液病医院(中国医学科学院血液学研究所),血液与健康全国重点实验室,国家血液系统疾病临床医学研究中心,细胞生态海河实验室,天津 300020
  2. 2 天津医学健康研究院,天津 301600
  3. 3 天津医科大学,细胞生态海河实验室,天津 300070
#共同第一作者
*通信作者

摘要

自然杀伤(NK)细胞在肿瘤治疗方面展现出的巨大潜力,使其成为免疫治疗领域的一个重要发展方向。NK 细胞特有的主要组织相容性复合物(MHC)非依赖性的杀伤活性,使其成为开发“现货型冶细胞治疗产品的理想载体。然而,当前 NK 细胞的临床应用仍面临诸多关键瓶颈,如肿瘤微环境对 NK 细胞的功能抑制、NK 细胞体内存续时间有限以及基因工程改造困难。 以成簇规律间隔短回文重复序列(CRISPR) /CRISPR相关蛋白 9(Cas9)为代表的基因编辑技术正在逐渐革新基因工程的范式,极大地促进了肿瘤免疫细胞治疗的基础和临床研究。 本文将综述 NK 细胞的生物学特性、基因工程及其在血液肿瘤免疫治疗中的应用,并探讨其面临的挑战与未来发展方向。

Applications and challenges of natural killer cell therapy in hematological malignancies

Yiwen WANG 1,2,#, Mengdi LI 3,#, Mingyi LIU 1,2, Shuquan RAO 1,2,*
Author Information
  1. 1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
  2. 2 Tianjin Institutes of Health Sciences, Tianjin 301600, China
  3. 3 Haihe Laboratory of Cell Ecosystem, Tianjin Medical University, Tianjin 300070, China
#Co-first author
*Corresponding author

Abstract

Natural killer (NK) cells have demonstrated substantial therapeutic potential in cancer treatment, positioning them as a major focus in the field of immunotherapy. Owing to their unique major histocompatibility complex (MHC) independent cytotoxic activity, NK cells represent an ideal platform for the development of “off-the-shelf” cell-based therapies. However, the clinical application of NK cells still faces several critical challenges, including functional suppression by the tumor microenvironment, limited in vivo persistence, and difficulties in genetic modification. Gene editing technologies, particularly clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9 (Cas9), are progressively transforming the paradigm of genetic engineering and have greatly advanced both basic and clinical research in tumor immunotherapy. This article reviews the biological characteristics of NK cells, their genetic engineering strategies, and their applications in immunotherapy for hematological malignancies, and further discusses the challenges they face and future development directions.

再生医学研究 Copyright © 2026. All Rights Reserved